Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Pharmacological blockade of NMDA receptor function induces apoptotic neurodegeneration in the developing rat brain. However, the use of NMDA receptor antagonists as anesthetics and sedatives represents a difficult-to-avoid clinical practice in pediatrics. This warrants the search for adjunctive neuroprotective measures that will prevent or ameliorate neurotoxicity of NMDA receptor antagonists. The NMDA receptor antagonist MK801 triggered apoptosis in the neonatal rat forebrain, most notably in cortex and thalamus. MK801 exposure reduced mRNA levels of erythropoietin (EPO) and the EPO receptor, suggesting that loss of endogenous EPO activity may contribute to MK801-induced apoptosis. Coadministration of recombinant EPO (rEPO) conferred 50% neuroprotection, partially restored MK801-induced reduction of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) mRNA, and prevented decreased phosphorylation levels of extracellular signal-regulated protein kinase-1/2 (ERK1/2) and Akt. These observations indicate that rEPO partly rescues newborn rats from MK801-mediated brain damage by enhancing neurotrophin-associated signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Comparative aspects of the brain growth spurt
Dobbing, J., & Sands, J. (1979) · Early Human Development · doi:10.1016/0378-3782(79)90022-7 · Cited by 2,506 · cited 1×
“In rats and mice, it is a postnatal event, but in humans, it extends from the sixth month of gestation to several years after birth (Dobbing and Sands, 1979).”
BackgroundBlockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Self-citationJevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., Olney, J. W., & Wozniak, D. F. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00876.2003 · Cited by 1,983
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Regulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
Unbiased stereological estimation of the number of neurons in the human hippocampus
West, M. J., & Gundersen, H. J. G. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902960102 · Cited by 1,153
Adolescents who were born very preterm have decreased brain volumes
Nosarti, C. (2002) · Brain · doi:10.1093/brain/awf157 · Cited by 406 · cited 1×
“Brain imaging studies of survivors of premature birth have demonstrated that cognitive deficits correlate with decreased volume of grey matter structures (Abernethy et al., 2002; Ajayi-Obe et al., 2000; Nosarti et al., 2002).”
BackgroundQuantitative magnetic resonance imaging of the brain in survivors of very low birth weight
Abernethy, L. J. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.4.279 · Cited by 157 · cited 1×
“Brain imaging studies of survivors of premature birth have demonstrated that cognitive deficits correlate with decreased volume of grey matter structures (Abernethy et al., 2002; Ajayi-Obe et al., 2000; Nosarti et al., 2002).”
Background
Cited by
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
New Avenues of Exploration for Erythropoietin
Maiese, K. (2005) · JAMA · doi:10.1001/jama.293.1.90 · Cited by 528
Erythropoietin as an antiapoptotic, tissue-protective cytokine
Ghezzi, P., & Brines, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401450 · Cited by 327
“In fact, PI(3)K is activated by EPO in the EPO-dependent UT-7 leukemia cell line, where it recruits Akt.28 This PI3K–Akt pathway also leads to upregulation of Bcl-xL and inhibition of apoptosis in Baf-3 cells.29 A further mechanism could be represented by NF-kB that is also a target of the PI3K-Akt pathway and mediate…”
BackgroundA Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
Juul, S. E., Comstock, B. A., Wadhawan, R., Mayock, D. E., Courtney, S. E., Robinson, T., Ahmad, K. A., Bendel-Stenzel, E., Baserga, M., LaGamma, E. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1907423 · Cited by 325
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Metadata
- Authors
- Dzietko, M., Felderhoff-Mueser, U., Sifringer, M., Krutz, B., Bittigau, P., Thor, F., Heumann, R., Bührer, C., Ikonomidou, C., & Hansen, H. H.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 15
- Issue
- 2
- Pages
- 177-187
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2085029073
- Cited by
- 139
- References
- 9
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity. https://app.cochat.ai/papers/10.1016/j.nbd.2003.10.006
- The paper
- Dzietko, M., Felderhoff-Mueser, U., Sifringer, M., Krutz, B., Bittigau, P., Thor, F., Heumann, R., Bührer, C., Ikonomidou, C., & Hansen, H. H. (2004). Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2003.10.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.